Journal
ANTIBIOTICS-BASEL
Volume 12, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/antibiotics12091462
Keywords
non-ribosomal anti-microbial peptides (NR-AMP); entomopathogenic nematode-symbiont bacteria (EPB); Xenorhabdus; X. budapestensis; X. szentirmaii; X. innexii; Photorhabdus (P. luminescens TT01); CFCM (cell-free conditioned culture media); kinetoplastid protozoa parasite; Leishmania; extracellular avian pathogens; Histomonas meleagridis; probiotic potential
Categories
Ask authors/readers for more resources
Anti-microbial peptides have a great potential in combating multidrug resistance. The symbiotic complex of entomopathogenic nematodes and entomopathogenic bacteria releases non-ribosomal templated anti-microbial peptides that may serve as potential drug candidates. Comparative anti-microbial bioassays revealed that Xenorhabdus budapestensis and X. szentirmaii are excellent sources of efficient non-ribosomal templated anti-microbial peptides, which can antagonize certain pathogens.
Anti-microbial peptides provide a powerful toolkit for combating multidrug resistance. Combating eukaryotic pathogens is complicated because the intracellular drug targets in the eukaryotic pathogen are frequently homologs of cellular structures of vital importance in the host organism. The entomopathogenic bacteria (EPB), symbionts of entomopathogenic-nematode species, release a series of non-ribosomal templated anti-microbial peptides. Some may be potential drug candidates. The ability of an entomopathogenic-nematode/entomopathogenic bacterium symbiotic complex to survive in a given polyxenic milieu is a coevolutionary product. This explains that those gene complexes that are responsible for the biosynthesis of different non-ribosomal templated anti-microbial protective peptides (including those that are potently capable of inactivating the protist mammalian pathogen Leishmania donovanii and the gallinaceous bird pathogen Histomonas meleagridis) are co-regulated. Our approach is based on comparative anti-microbial bioassays of the culture media of the wild-type and regulatory mutant strains. We concluded that Xenorhabdus budapestensis and X. szentirmaii are excellent sources of non-ribosomal templated anti-microbial peptides that are efficient antagonists of the mentioned pathogens. Data on selective cytotoxicity of different cell-free culture media encourage us to forecast that the recently discovered easy-PACId research strategy is suitable for constructing entomopathogenic-bacterium (EPB) strains producing and releasing single, harmless, non-ribosomal templated anti-microbial peptides with considerable drug, (probiotic)-candidate potential.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available